Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

• Ken-Hong Lim,
• Ken-Hong Lim,
• Shinobu Matsuura,
• Bing Xu,
• Bing Xu

Affiliations

Ken-Hong Lim

Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei City, Taiwan

Ken-Hong Lim

Department of Medicine, MacKay Medical College, New Taipei City, Taiwan

Shinobu Matsuura

Department of Medicine–Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, United States

Bing Xu

Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China

Bing Xu

Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China